ReviewJournal of the advanced practitioner in oncology2018

Drug-Drug Interactions, Safety, and Pharmacokinetics of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer.

Colleen R Kucharczuk et al.PubMed ↗Full text ↗

No numbers read from the abstract.